(Q38235283)

31 August 2017

title

Neonatal pertussis, cocooning and maternal immunization (English)

1 reference

31 August 2017

0 references

0 references

Geeta K Swamy

1

1 reference

31 August 2017

Sarahn M Wheeler

series ordinal

2

1 reference

31 August 2017

publication date

30 July 2014

1 reference

Expert Review of Vaccines

31 August 2017

published in

1 reference

31 August 2017

volume

13

1 reference

31 August 2017

issue

9

1 reference

31 August 2017

page(s)

1107-1114

1 reference

The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

Increase in pertussis may be due to increased recognition and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

Duration of immunity against pertussis after natural infection or vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

Clinical and laboratory features of pertussis in infants at the onset of a California epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

Severe and unrecognised: pertussis in UK infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

Clinical characteristics and outcomes of neonatal pertussis: a comparative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

Pathology and pathogenesis of fatal Bordetella pertussis infection in infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

Bordetella pertussis infection: pathogenesis, diagnosis, management, and the role of protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

Pertussis Pseudo-outbreak linked to specimens contaminated by Bordetella pertussis DNA From clinic surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

Bordetella holmesii: an under-recognised Bordetella species

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

Bordetella holmesii in children suspected of pertussis in Argentina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

Critical pertussis illness in children: a multicenter prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

Pertussis hospitalizations among infants in the United States, 1993 to 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

Poor immune responses to a birth dose of diphtheria, tetanus, and acellular pertussis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

Booster vaccination after neonatal priming with acellular pertussis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

Transmission of Bordetella pertussis to young infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

Infant pertussis: who was the source?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

Sources of pertussis infection in young infants: a review of key evidence informing targeting of the cocoon strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

Evaluation of several approaches to immunize parents of neonates against B. pertussis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

A cross sectional survey of attitudes, awareness and uptake of the parental pertussis booster vaccine as part of a cocooning strategy, Victoria, Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

Pregnancy dose Tdap and postpartum cocooning to prevent infant pertussis: a decision analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

Cost-effectiveness analysis of various pertussis vaccination strategies primarily aimed at protecting infants in the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

Parent "cocoon" immunization to prevent pertussis-related hospitalization in infants: the case of Piemonte in Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

Cost-effectiveness of targeted vaccination to protect new-borns against pertussis: comparing neonatal, maternal, and cocooning vaccination strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

Effectiveness of maternal influenza immunization in mothers and infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

Effectiveness of pertussis vaccines for adolescents and adults: case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

Vaccines for pertussis and influenza: recommendations for use in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

Prevention of pertussis, tetanus, and diphtheria among pregnant, postpartum women, and infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

Immune responses in infants whose mothers received Tdap vaccine during pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

The safety of immunizing with tetanus-diphtheria-acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: Experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

Cocooning infants: Tdap immunization for new parents in the pediatric office

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944509

10.1586/14760584.2014.944509

21 January 2018

Identifiers

DOI

1 reference

31 August 2017

1 reference